Back to Search
Start Over
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study
- Source :
- Journal of Medical Economics. 22:1006-1013
- Publication Year :
- 2019
- Publisher :
- Informa UK Limited, 2019.
-
Abstract
- Purpose: The EF-14 trial demonstrated that adding tumor treating fields (TTFields) to maintenance temozolomide (TMZ) significantly extends progression-free survival (PFS) and overall survival (OS) ...
- Subjects :
- Oncology
medicine.medical_specialty
Cost effectiveness
Cost-Benefit Analysis
Newly diagnosed
Disease-Free Survival
03 medical and health sciences
0302 clinical medicine
Conditional survival
Internal medicine
Long term survival
Temozolomide
medicine
Overall survival
Humans
Antineoplastic Agents, Alkylating
business.industry
030503 health policy & services
Health Policy
medicine.disease
Combined Modality Therapy
030220 oncology & carcinogenesis
Glioblastoma
0305 other medical science
business
medicine.drug
Subjects
Details
- ISSN :
- 1941837X and 13696998
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Journal of Medical Economics
- Accession number :
- edsair.doi.dedup.....556d16ce4791e6e556223704da0bb1a3
- Full Text :
- https://doi.org/10.1080/13696998.2019.1614933